Neoadjuvant versus adjuvant imatinib in primary localized gastrointestinal stromal tumor

BACKGROUND: The effect of neoadjuvant therapy (NAT) with imatinib versus upfront resection (UR) followed by adjuvant therapy (AT) with imatinib on the outcomes of gastrointestinal stromal tumors (GIST) is unknown. METHODS: This is a retrospective study at a high-volume center. All the patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ling, Jiayu, Shi, Lishuo, Cheng, Xingyu, Fu, Yang, Lin, Ziqin, Zhao, Yandong, Li, Zheqing, Zhang, Jianwei, Hu, Huabin, Cai, Yue, Deng, Yanhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007957/
https://www.ncbi.nlm.nih.gov/pubmed/36915468
http://dx.doi.org/10.21037/jgo-22-931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007957/
https://www.ncbi.nlm.nih.gov/pubmed/36915468
http://dx.doi.org/10.21037/jgo-22-931

Ejemplares similares